Shopping Cart
- Remove All
Your shopping cart is currently empty
FRAX-1036 is a effective and selective PAK1 inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $47 | In Stock | |
| 2 mg | $63 | In Stock | |
| 5 mg | $89 | In Stock | |
| 10 mg | $122 | In Stock | |
| 25 mg | $222 | In Stock | |
| 50 mg | $372 | In Stock | |
| 100 mg | $538 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $98 | In Stock |
| Description | FRAX-1036 is a effective and selective PAK1 inhibitor. |
| Targets&IC50 | PAK1:23.3 nM(Ki), PAK2:72.4 nM(Ki), PAK4:2.4 μM(Ki) |
| In vitro | MDA-MB-175 cells,which are PAK1-amplified (MEK1-S298 and CRAF-S338) ,was observed Potent cellular inhibition at 2.5 to 5 μM concentrations of FRAX1036. PAK1-amplified breast cancer cells are treated with FRAX1036 leading to apoptosis. OVCAR-3 cells are treated with FRAX-1036 resulting in upregulation of p53 and p21, while down-regulating cyclin B1. |
| In vivo | KT21 are treated with Frax1036 showing slower tumor growth, while Frax1036 is unlikely to have significant blood-brain barrier permeability in mice. |
| Cell Research | MDA-MB175 cells are treated with increasing concentrations (0, 0.5, 1, 2.5, 5 μM) of FRAX1036 for 24 hours. |
| Animal Research | Pak2-deficient mice were treated by oral gavage of 30 mg/kg Frax1036. |
| Molecular Weight | 518.05 |
| Formula | C28H32ClN7O |
| Cas No. | 1432908-05-8 |
| Smiles | CCn1c2nc(NCCC3CCN(C)CC3)ncc2cc(-c2ccc(cc2Cl)-c2cncc(C)n2)c1=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: insoluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.